Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: MacroRisk Analytics/EconomicInvestor
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Teva Pharmaceutical Industries Ltd Narrows FY 2013 Guidance

Thursday, 31 Oct 2013 08:30am EDT 

Teva Pharmaceutical Industries Ltd announced that for fiscal 2013, it expects net revenue to be between $19.7-$20.3 billion and non-GAAP diluted earnings per share (EPS) to be between $4.95-5.05 According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $20.1 billion and EPS of $5.01 for fiscal 2013. 

Company Quote

0.33 +0.58%
24 Dec 2014